Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytes
- 31 August 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 122 (2) , 578-584
- https://doi.org/10.1016/0008-8749(89)90104-4
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Generation and expansion of lymphokine-activated killer cells from lymph node lymphocytes in human lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Human Cytotoxic T Cells Specific for Autologous Melanoma Cells: Successful Generation From Lymph Node Cells in Seven Consecutive CasesJNCI Journal of the National Cancer Institute, 1988
- Antitumor activity of regional lymph node lymphocytes in patients with lung cancerJournal of Surgical Oncology, 1988
- Human T Cells Specifically Activated Against Autologous Malignant MelanomaArchives of Surgery, 1987
- Lymphokine-activated killer cells. Analysis of progenitors and effectors.The Journal of Experimental Medicine, 1986
- Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.The Journal of Experimental Medicine, 1986
- Purification and characterization of recombinant human interleukin-2 produced in Escherichia coliBiochemical and Biophysical Research Communications, 1985
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982